Suppr超能文献

亨廷顿病患者外周血淋巴细胞中非神经元基因中阻遏元件-1 沉默转录因子/神经元抑制因子结合位点的分析。

Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease.

机构信息

Department of Pharmacological Sciences and Center for Stem Cell Research, University of Milan, Milan, Italy.

出版信息

Brain Pathol. 2010 Jan;20(1):96-105. doi: 10.1111/j.1750-3639.2008.00249.x. Epub 2008 Dec 23.

Abstract

We have previously demonstrated that the transcription of neuronal repressor element-1/neuron-restrictive silencer element (RE1/NRSE)-regulated genes is reduced in the brain of subjects with Huntington's disease (HD) as a result of increased binding of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) to its RE1/NRSE targets. As specific non-neuronal REST/NRSF-regulated genes have been identified in the human genome, we exploited the possibility that the binding of REST/NRSF to its target RE1/NRSE sites may also be altered in the peripheral tissues of HD patients. Our results show that REST/NRSF occupancy is increased in lymphocytes from HD subjects, thus indicating for the first time that the activity of the RE1/NRSE sites is dysfunctional in vivo. Chromatin immunoprecipitation (ChIP) of the RE1/NRSE sites in lymphocytes may therefore be a reproducible, sensitive and specific means of searching for candidate markers of HD onset and progression.

摘要

我们之前已经证明,由于抑制元件-1/神经元抑制性沉默元件(RE1/NRSE)调节基因的转录因子的结合增加,亨廷顿病(HD)患者大脑中的神经元抑制元件-1 沉默转录因子/神经元抑制因子(REST/NRSF)到其 RE1/NRSE 靶标。由于在人类基因组中已经鉴定出了特定的非神经元 REST/NRSF 调节基因,因此我们利用了 REST/NRSF 与其靶标 RE1/NRSE 结合也可能在 HD 患者的外周组织中改变的可能性。我们的结果表明,HD 患者的淋巴细胞中 REST/NRSF 的占有率增加,这表明体内 RE1/NRSE 位点的活性失常。因此,淋巴细胞中 RE1/NRSE 位点的染色质免疫沉淀(ChIP)可能是一种可重复、敏感和特异的寻找 HD 发病和进展候选标志物的方法。

相似文献

4
Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target.
Curr Pharm Des. 2009;15(34):3958-67. doi: 10.2174/138161209789649303.
5
Genome-wide identification of target genes repressed by the zinc finger transcription factor REST/NRSF in the HEK 293 cell line.
Acta Biochim Biophys Sin (Shanghai). 2009 Dec;41(12):1008-17. doi: 10.1093/abbs/gmp095.
9
Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes.
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10458-63. doi: 10.1073/pnas.0401827101. Epub 2004 Jul 6.

引用本文的文献

1
REST Is Not Resting: REST/NRSF in Health and Disease.
Biomolecules. 2023 Oct 2;13(10):1477. doi: 10.3390/biom13101477.
2
REST promotes ETS1-dependent vascular growth in medulloblastoma.
Mol Oncol. 2021 May;15(5):1486-1506. doi: 10.1002/1878-0261.12903. Epub 2021 Feb 7.
3
Mitochondrial Respiratory Function in Peripheral Blood Cells from Huntington's Disease Patients.
Mov Disord Clin Pract. 2016 Feb 11;3(5):472-482. doi: 10.1002/mdc3.12308. eCollection 2016 Sep-Oct.
5
Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells.
Stem Cell Reports. 2015 Jan 13;4(1):37-46. doi: 10.1016/j.stemcr.2014.10.015. Epub 2014 Dec 4.
6
ChIP-Seq Data Mining: Remarkable Differences in NRSF/REST Target Genes between Human ESC and ESC-Derived Neurons.
Bioinform Biol Insights. 2013 Dec 1;7:357-68. doi: 10.4137/BBI.S13279. eCollection 2013.
7
Developing epigenetic diagnostics and therapeutics for brain disorders.
Trends Mol Med. 2013 Dec;19(12):732-41. doi: 10.1016/j.molmed.2013.09.003. Epub 2013 Oct 18.
9
Advances in epigenetics and epigenomics for neurodegenerative diseases.
Curr Neurol Neurosci Rep. 2011 Oct;11(5):464-73. doi: 10.1007/s11910-011-0210-2.
10
Long non-coding RNAs in nervous system function and disease.
Brain Res. 2010 Jun 18;1338:20-35. doi: 10.1016/j.brainres.2010.03.110. Epub 2010 Apr 7.

本文引用的文献

1
Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.
Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14424-9. doi: 10.1073/pnas.0703652104. Epub 2007 Aug 27.
3
Transcriptional signatures in Huntington's disease.
Prog Neurobiol. 2007 Nov;83(4):228-48. doi: 10.1016/j.pneurobio.2007.03.004. Epub 2007 Apr 1.
4
Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication.
Nucleic Acids Res. 2006;34(14):3862-77. doi: 10.1093/nar/gkl525. Epub 2006 Aug 9.
5
Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease.
Neurobiol Dis. 2006 May;22(2):233-41. doi: 10.1016/j.nbd.2005.11.001. Epub 2006 Jan 24.
6
Normal huntingtin function: an alternative approach to Huntington's disease.
Nat Rev Neurosci. 2005 Dec;6(12):919-30. doi: 10.1038/nrn1806.
7
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11023-8. doi: 10.1073/pnas.0504921102. Epub 2005 Jul 25.
8
Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes.
Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10458-63. doi: 10.1073/pnas.0401827101. Epub 2004 Jul 6.
9
Interaction of the repressor element 1-silencing transcription factor (REST) with target genes.
J Mol Biol. 2003 Dec 12;334(5):863-74. doi: 10.1016/j.jmb.2003.10.017.
10
Distinct RE-1 silencing transcription factor-containing complexes interact with different target genes.
J Biol Chem. 2004 Jan 2;279(1):556-61. doi: 10.1074/jbc.M310353200. Epub 2003 Oct 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验